Eczema and Aging Skin: Managing Flare-Ups in Older Adults
How eczema affects aging skin differently, with strategies for managing flare-ups, preventing complications, and maintaining comfort in older adults.
Eczema—or atopic dermatitis—is often thought of as a childhood condition, but it affects millions of older adults and frequently appears for the first time after age 60. In aging skin, eczema presents differently, heals more slowly, and carries greater risk of complications. Managing it effectively requires understanding these differences and adapting treatment strategies to the unique vulnerabilities of mature skin.
Eczema in Older Adults: A Growing Recognition
For decades, eczema in seniors was underdiagnosed and undertreated. The medical community focused primarily on pediatric eczema, and many cases in older adults were misdiagnosed as simple dry skin (xerosis) or attributed to other conditions.
Recent research has shed light on the true prevalence. Studies suggest that eczema affects approximately 2% to 10% of adults over 60, with many cases representing new onset rather than persistence from childhood. This "elderly-onset" atopic dermatitis has its own characteristics and triggers that distinguish it from the childhood form.
How Senior Eczema Differs
In younger patients, eczema typically appears in the folds of the elbows and knees, on the face, and on the hands. In older adults, the distribution often differs. Eczema is more likely to be generalized, affecting large body surface areas rather than limited patches. The trunk and extremities are commonly involved. Nummular (coin-shaped) patterns are more frequent. The skin tends to be more intensely dry and scaly rather than oozing or weeping.
The itch of elderly eczema can be particularly severe and debilitating. Because aging skin is already prone to dryness and barrier compromise, the itch-scratch cycle that characterizes eczema can escalate rapidly, leading to skin tears, bleeding, and secondary infection in fragile tissue.
What Triggers Eczema in Seniors
Barrier Dysfunction
The age-related decline in skin barrier function creates conditions ripe for eczema development. Reduced ceramide levels, diminished sebum production, and slower cell turnover all contribute to a barrier that can no longer effectively prevent allergen penetration and water loss—two key drivers of eczema flares.
Environmental Factors
Low humidity, particularly during winter months with indoor heating, is one of the most common triggers. Harsh soaps, detergents, and cleaning products strip an already-compromised barrier. Wool and synthetic fabrics can cause mechanical irritation. Temperature extremes stress the skin's regulatory capacity.
Medications
Certain medications can trigger or worsen eczema-like reactions. Calcium channel blockers, beta-blockers, and some antibiotics have been associated with eczematous drug eruptions that mimic primary eczema. Any new medication coinciding with a skin flare deserves discussion with your prescribing physician.
Immune Changes
Immunosenescence—the gradual decline in immune function with age—paradoxically contributes to eczema. While overall immune capacity decreases, the balance between different immune pathways shifts, sometimes favoring the Th2-dominant inflammatory response that drives eczema.
Contact Allergens
Years of exposure can lead to new contact allergies developing later in life. Common culprits in seniors include fragrances in personal care products, preservatives (particularly methylisothiazolinone), nickel in jewelry or belt buckles, topical medications (including neomycin and bacitracin), and rubber chemicals in gloves and elastic waistbands.
Patch testing—where small amounts of common allergens are applied to the back under occlusion—can identify specific triggers and guide avoidance strategies.
Management Strategies
Gentle Skin Care Foundation
The foundation of eczema management in seniors mirrors barrier repair principles but with extra emphasis on gentleness.
Bathing: Limit to once daily or every other day. Use lukewarm water for no more than 10 minutes. Use a soap-free, fragrance-free cleansing cream. Apply only to areas that need cleaning—don't lather the entire body.
Moisturizing: Apply a thick, ceramide-containing cream or ointment within three minutes of bathing. Reapply to affected areas two to three times daily. Ointments (petrolatum-based) are generally more effective than creams for eczema-prone skin because they provide better occlusion and contain fewer potentially irritating ingredients.
Clothing: Wear soft, breathable cotton next to the skin. Wash new clothes before wearing to remove manufacturing chemicals. Use fragrance-free, dye-free laundry detergent. Skip fabric softeners and dryer sheets, which leave irritating chemical residues on fabric.
Topical Anti-Inflammatory Treatments
When moisturizing alone doesn't control flares, anti-inflammatory treatments become necessary.
Topical corticosteroids remain the first-line treatment for eczema flares. However, in elderly skin, steroid selection and use require extra caution. Thin, fragile skin is more susceptible to steroid side effects—atrophy, striae, telangiectasia, and bruising. Use the lowest potency that effectively controls the flare, and limit continuous use to two weeks before reassessing.
Low-potency steroids (hydrocortisone 1% to 2.5%) are appropriate for the face, neck, and skin folds. Medium-potency steroids may be needed for thicker skin on the trunk and extremities. Avoid high-potency steroids on thin-skinned areas entirely.
Topical calcineurin inhibitors (tacrolimus ointment and pimecrolimus cream) are steroid-sparing alternatives that don't cause skin atrophy. They're particularly valuable for sensitive areas (face, skin folds) and for long-term maintenance. Initial application may cause a temporary burning sensation that typically resolves with continued use.
Crisaborole (a topical PDE4 inhibitor) is another non-steroidal option for mild to moderate eczema. It's well tolerated by most patients and doesn't carry the atrophy risk of corticosteroids.
Systemic Treatments for Severe Cases
When topical treatments prove insufficient—and severe eczema significantly impacts quality of life—systemic options may be appropriate.
Dupilumab (a biologic injectable medication) has transformed severe eczema management. It targets specific inflammatory pathways (IL-4 and IL-13) with remarkable effectiveness and a favorable safety profile, including in older patients. Studies in elderly patients show efficacy and tolerability comparable to younger populations.
Traditional systemic immunosuppressants (cyclosporine, methotrexate, azathioprine) are sometimes used but require careful monitoring in seniors due to their broader immunosuppressive effects and potential interactions with other medications.
JAK inhibitors (oral medications like abrocitinib and upadacitinib) represent a newer class of eczema treatments. Their use in seniors requires careful consideration of cardiovascular risk, as some JAK inhibitors carry boxed warnings regarding cardiovascular events in older patients.
Itch Management
Controlling the itch is often the most urgent priority for patients and the biggest challenge for clinicians. Beyond anti-inflammatory treatments, additional itch-management strategies include applying cool, wet compresses to intensely itchy areas, using menthol-containing moisturizers for cooling relief, keeping nails very short to minimize scratch damage, wearing cotton gloves at night to prevent sleep-scratching, and using a humidifier to maintain indoor humidity between 40% and 60%.
Sedating antihistamines (diphenhydramine, hydroxyzine) were traditionally used for nighttime itch relief but should be used cautiously in seniors due to anticholinergic side effects, fall risk, and cognitive effects. Non-sedating alternatives have limited effect on eczema itch specifically.
Preventing Complications
Skin Infections
Eczema-damaged skin is vulnerable to bacterial infection—particularly Staphylococcus aureus, which colonizes the skin of nearly 90% of eczema patients. In elderly patients with compromised immune function, these infections can become serious.
Watch for signs of infection: increased redness, warmth, swelling, pain, crusting (particularly honey-colored crusting suggesting impetigo), or fever. Prompt treatment with appropriate antibiotics is essential.
Eczema Herpeticum
Herpes simplex virus can spread rapidly across eczema-damaged skin in a potentially dangerous condition called eczema herpeticum. Grouped, painful blisters or punched-out erosions in an eczema patient should prompt immediate medical evaluation.
Living Well with Eczema
Eczema in older adulthood can feel isolating and demoralizing, particularly when it's severe or treatment-resistant. The visible skin changes and relentless itching affect sleep, mood, social engagement, and overall quality of life.
Working closely with a dermatologist who understands senior eczema ensures you receive appropriate, individualized treatment. Support from family and friends, attention to mental health, and the reassurance that effective treatments exist all contribute to managing not just the skin disease but its impact on your life as a whole.
Eczema in aging skin is manageable. With the right combination of gentle care, appropriate treatment, trigger avoidance, and professional guidance, even persistent eczema can be brought under control—restoring comfort and confidence.